VYVECLIS Trademark

Trademark Overview

On Tuesday, March 8, 2022, a trademark application was filed for VYVECLIS with the United States Patent and Trademark Office. The USPTO has given the VYVECLIS trademark a serial number of 97300787. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, December 27, 2024. This trademark is owned by Shionogi & Co., Ltd.. The VYVECLIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of infectious diseases caused by viruses; antivirals
vyveclis

General Information

Serial Number97300787
Word MarkVYVECLIS
Filing DateTuesday, March 8, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, December 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 22, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of infectious diseases caused by viruses; antivirals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, March 12, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameShionogi & Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOsaka-shi, Osaka 541-0045
JP
Party NameShionogi & Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOsaka-shi, Osaka 541-0045
JP

Trademark Events

Event DateEvent Description
Friday, March 11, 2022NEW APPLICATION ENTERED
Saturday, March 12, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 16, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, March 18, 2022ASSIGNED TO LIE
Friday, March 18, 2022PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Friday, September 23, 2022ASSIGNED TO EXAMINER
Friday, October 14, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 20, 2022ASSIGNED TO EXAMINER
Wednesday, November 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 22, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 17, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 26, 2023SOU TEAS EXTENSION RECEIVED
Monday, June 26, 2023SOU EXTENSION 1 FILED
Monday, June 26, 2023SOU EXTENSION 1 GRANTED
Wednesday, June 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 27, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, December 27, 2023SOU EXTENSION 2 FILED
Wednesday, December 27, 2023SOU EXTENSION 2 GRANTED
Friday, December 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 24, 2024SOU TEAS EXTENSION RECEIVED
Monday, June 24, 2024SOU EXTENSION 3 FILED
Monday, June 24, 2024SOU EXTENSION 3 GRANTED
Monday, June 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 27, 2024SOU TEAS EXTENSION RECEIVED
Friday, December 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 27, 2024SOU EXTENSION 4 GRANTED
Friday, December 27, 2024SOU EXTENSION 4 FILED

Related Keywords

vyveclis caused viruses antivirals diseases infectious preparations treatment pharmaceutical